ADIPOQ and non-small cell lung carcinoma: Reports reveal decreased adiponectin in breast and endometrial cancer and vice versa in non-small cell lung cancer, pancreatic, liver, prostate, gastric, renal cell carcinoma, and colon cancer [115,116,117,118].